These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 1149988)

  • 1. Role of phosphate depletion and high dialysate calcium in controlling dialytic renal osteodystrophy.
    Goldsmith RS; Johnson WJ
    Kidney Int; 1973 Aug; 4(2):154-60. PubMed ID: 4744973
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hexa-calcium-hexa-sodium-hepta-citrate hydrate complex for prophylaxis and treatment of renal osteopathy in chronic hemodialysis].
    Albert FW; Schmidt U; Schäfer K
    Med Welt; 1973 Feb; 24(5):185-7. PubMed ID: 4805391
    [No Abstract]   [Full Text] [Related]  

  • 3. The investigation and treatment of renal bone disease.
    Catto GR; MacLeod M
    Am J Med; 1976 Jul; 61(1):64-73. PubMed ID: 937372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can a dietitian help prevent renal bone disease in the hemodialysis patient?
    Harum P
    Nephrol News Issues; 1990 Sep; 4(9):35, 37, 42. PubMed ID: 2402318
    [No Abstract]   [Full Text] [Related]  

  • 5. [Physiopathology of renal osteodystrophy. I. Patients with kidney failure without dialysis].
    Fournier A; Bordier P; Weil B; Safar M; Idatte JM
    Presse Med (1893); 1971 Oct; 79(45):2017-21. PubMed ID: 5119047
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experience in the behavior and control of renal osteodystrophy in patients under chronic hemodialysis].
    Treviño Becerra A
    Gac Med Mex; 1975 Jun; 109(6):411-20. PubMed ID: 1149988
    [No Abstract]   [Full Text] [Related]  

  • 7. Calcium carbonate and magnesium hydroxide in the prevention of renal osteodystrophy or the demise of aluminum toxicity in uremia. Analysis of 5 years experience.
    Morinière P; Fournier A; Westeel PF; Idrissi A; Renaud H; Hocine C; Belbrik S; Marie A; Leflon P; Sebert JL
    Contrib Nephrol; 1988; 64():58-73. PubMed ID: 3053039
    [No Abstract]   [Full Text] [Related]  

  • 8. [Calcium metabolism in chronic uraemia and in patients on chronic intermittent haemodialysis (author's transl)].
    Skrabal F; Dittrich P
    Wien Klin Wochenschr; 1974 Apr; 86(7):169-77. PubMed ID: 4207089
    [No Abstract]   [Full Text] [Related]  

  • 9. How KDIGO will (or will not) influence the management of hyperphosphatemia.
    Kovesdy CP
    Semin Dial; 2011; 24(1):35-6. PubMed ID: 21338391
    [No Abstract]   [Full Text] [Related]  

  • 10. [Adequate dialysis].
    Maduell Canals F
    Nefrologia; 2002; 22(2):111-34. PubMed ID: 12085413
    [No Abstract]   [Full Text] [Related]  

  • 11. A daunting task but largely successful in developing meaningful guidelines.
    O'Neill WC
    Semin Dial; 2011; 24(1):24-7. PubMed ID: 21338388
    [No Abstract]   [Full Text] [Related]  

  • 12. Aluminum-related osteodystrophy.
    Sherrard DJ; Andress DL
    Adv Intern Med; 1989; 34():307-23. PubMed ID: 2644762
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.